Amicus Therapeutics Inc (FOLD) — Cash Flow Reinvestment Rate
Amicus Therapeutics Inc (FOLD) has a Cash Flow Reinvestment Rate of 0.40x as of December 2025, reinvesting $6.49 Million (capex $299.00K plus investments $-6.20 Million) from operating cash flow of $16.25 Million. Check FOLD cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amicus Therapeutics Inc Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Amicus Therapeutics Inc across 2 annual periods. Explore FOLD strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Amicus Therapeutics Inc (2007–2025)
Year-by-year capital reinvestment analysis for Amicus Therapeutics Inc. For live market cap and broader valuation context, see FOLD market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | $46.43 Million | $33.15 Million | $3.30 Million | ▲ +3081.2% |
| 2007 | 0.04x | $669.00K | $15.19 Million | $669.00K | — |